Article Text

PDF
Towards a dynamic customised therapy for ocular surface dysfunctions
  1. Pasquale Aragona1,
  2. Maurizio Rolando2,3
  1. 1Department of Surgical Specialties, Section of Ophthalmology, University of Messina, Messina, Italy
  2. 2Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI) of the University of Genoa, Clinica Oculistica, Genoa, Italy
  3. 3Is.Pre. Oftalmica, Genoa, Italy
  1. Correspondence to Professor Maurizio Rolando, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), Clinica Oculistica, University of Genoa, viale Benedetto XV-5, Genoa 16132, Italy; maurizio.rolando{at}gmail.com

Abstract

The ocular surface is a highly dynamic system characterised by continuous adaptive reactions to environmental, toxic, infective, traumatic and inflammatory conditions that interfere with its homeostasis. When the adaptive response is not able to cope with environmental or internal aggressions, a persisting dysfunction may develop into a self-maintaining vicious cycle, thereby developing a chronic disease. This process is not even, but characterised by cycles of worsening and improvement accompanied by morphofunctional changes of the ocular surface structure. The therapy for this condition cannot be unique and stable all along the course of the disease, but should be adapted to the modifications occurring on the ocular surface. It should be long term and dynamic, in order to be tailored on each patient's conditions. An ideal therapeutic strategy should address simultaneously the main targets: tear film quality and stability, morphofunctional changes of the epithelia, the obvious and subclinical inflammation, and the structural and functional changes of nerves.

The avoidance of schematic approaches and the customisation of the therapy, modified according to the disease presentation, will be highly desirable and will open to a patient-oriented approach, granting a more prompt and stable improvement of the ocular surface with better-tolerated therapies.

  • Ocular surface
  • Tears
  • Conjunctiva
  • Cornea
  • Treatment Medical

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.